Genvor Incorporated (GNVR)
OTCMKTS · Delayed Price · Currency is USD
0.5000
-0.0100 (-1.96%)
At close: Jun 16, 2026
Genvor Employees
Genvor had 5 employees as of September 30, 2025. The number of employees increased by 4 or 400.00% compared to the previous year.
Employees
5
Change (1Y)
4
Growth (1Y)
400.00%
Revenue / Employee
n/a
Profits / Employee
-$258,931
Market Cap
18.11M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 5 | 4 | 400.00% |
| Sep 30, 2024 | 1 | - | - |
Genvor News
- 5 weeks ago - Genvor Appoints Donald Kalkofen as Chief Financial Officer - GlobeNewsWire
- 2 months ago - Genvor Announces Strategic Memorandum of Understanding with Canlab International™ to Advance Commercial Peptide Pipeline - GlobeNewsWire
- 4 months ago - Genvor, Inc. Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Accesswire
- 4 months ago - Genvor Announces Strategic Expansion into Health and Wellness Market, Leveraging Proprietary AI-Accelerated BioCypher Platform to Develop Consumer Peptide Solutions - GlobeNewsWire
- 4 months ago - Genvor's AGM182 Antifungal Peptide Technology Validated in Peer-Reviewed Publication in PhytoFrontiers™ - GlobeNewsWire
- 5 months ago - Genvor Appoints Dr. George Stavrides as Executive Vice President, Business Development & Commercialization - GlobeNewsWire
- 7 months ago - Genvor to Present at the Life Sciences Virtual Investor Forum December 11th - GlobeNewsWire
- 7 months ago - Genvor and Tuskegee University Announce Teaming Agreement to Advance Peptide Research and Sustainable Crop Protection Technologies - GlobeNewsWire